Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for Late Preterm Infants
NCT06026163Phase 3Recruiting
- Sponsor
- Ministry of Health
- Start
- Oct 2023
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caffeine in respiratory distress syndrome (RDS), apnea of prematurity (AOP), sponsored by Ministry of Health. Started Oct 2023; status: recruiting.
02
Drugs
caffeine
03
Conditions
respiratory distress syndrome (RDS)apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT06026163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06026163.